Continuum Advisory’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8K Buy
+113
New +$10.8K ﹤0.01% 1237
2025
Q2
Sell
-245
Closed -$36K 616
2025
Q1
$36K Buy
245
+12
+5% +$1.83K ﹤0.01% 753
2024
Q4
$37.8K Buy
233
+49
+27% +$8.02K ﹤0.01% 718
2024
Q3
$30.4K Buy
184
+138
+300% +$20.4K ﹤0.01% 750
2024
Q2
$6.23K Sell
46
-10
-18% -$1.39K ﹤0.01% 1046
2024
Q1
$7.88K Buy
+56
New +$8.36K ﹤0.01% 1000
2021
Q2
Sell
-1,789
Closed -$343K 271
2021
Q1
$343K Sell
1,789
-6,502
-78% -$1.25M 0.14% 127
2020
Q4
$1.67M Buy
8,291
+646
+8% +$134K 0.76% 39
2020
Q3
$1.62M Buy
7,645
+701
+10% +$156K 0.89% 32
2020
Q2
$1.52M Buy
6,944
+1,474
+27% +$294K 0.96% 28
2020
Q1
$955K Buy
+5,470
New +$904K 0.64% 44

Other funds holding CLX

Continuum Advisory's CLX Position: Q2 2026 in Review

Continuum Advisory opened a new position in Clorox (CLX) in Q2 2026: 113 shares worth $10.8K. The stake represents ﹤0.01% of the portfolio and ranks #1237 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in CLX as recently as Q1 2025.

Continuum Advisory first reported a position in CLX in Q1 2020 and has held it in 11 quarters since. The position peaked at $1.67M in Q4 2020. 1,050 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Continuum Advisory held 113 shares of Clorox worth $10.8K as of Q2 2026.
  • Clorox was a new Continuum Advisory position in Q2 2026.
  • Clorox made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1237 holding.
  • Continuum Advisory first reported a position in Clorox in Q1 2020 and has held it in 11 quarters since.
  • Continuum Advisory's Clorox position peaked at $1.67M in Q4 2020.
  • 1,050 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.